{"id":"NCT02547623","sponsor":"ICON Bioscience Inc","briefTitle":"Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery","officialTitle":"A Phase 3, Prospective, Randomized, Parallel-design, Multicenter Study to Evaluate the Safety of Icon Bioscience-10090 for the Treatment of Inflammation Associated With Cataract Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11-06","primaryCompletion":"2016-08-16","completion":"2016-08-16","firstPosted":"2015-09-11","resultsPosted":"2018-06-19","lastUpdate":"2018-08-21"},"enrollment":194,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cataract"],"interventions":[{"type":"DRUG","name":"Dexamethasone","otherNames":["Dexycu"]},{"type":"DRUG","name":"Prednisolone","otherNames":["standard of care"]}],"arms":[{"label":"dexamethasone depot","type":"ACTIVE_COMPARATOR"},{"label":"standard of care","type":"ACTIVE_COMPARATOR"}],"summary":"The study is a prospective, randomized, parallel-design, multicenter trial in patients â‰¥40 years of age undergoing cataract surgery. Patients who meet all inclusion and no exclusion criteria will be randomized to 1 of 2 treatment groups\n\n* A single 5 mcl anterior chamber injection of IBI 10090, 103.4 mcg/mcl dexamethasone, equivalent dexamethasone dose: 517 mcg at the conclusion of cataract surgery or;\n* Prednisolone acetate ophthalmic suspension 1% eye drops administered 1 drop 4 times daily (QID) for 3 weeks Safety will be assessed by adverse events (AEs), slit lamp biomicroscopy, fundus examination, intraocular pressure (IOP), visual acuity, and specular microscopy endothelial cell count.","primaryOutcome":{"measure":"Number of Participants With Treatment-Emergent Adverse Events (TEAEs)","timeFrame":"Baseline to postoperative day 90/ early termination","effectByArm":[{"arm":"Dexamethasone Depot","deltaMin":53,"sd":null},{"arm":"Prednisolone Drops 1% (Standard of Care)","deltaMin":13,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":11,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":126},"commonTop":["Intraocular pressure increased","Iritis","Headache"]}}